Zibotentan
Zibotentan is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants
Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
Precision Medicine With Zibotentan in Microvascular Angina
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
Clinical Trials (8)
A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants
Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
Precision Medicine With Zibotentan in Microvascular Angina
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal Impairment
Zibotentan Better Renal Scleroderma Outcome Study
Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8